Biomarker panel to elevate prostate cancer diagnostics: Berg

The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option.

Click here to view the full article at Outsourcing-Pharma.com.